INSIGHTS ON CLINICAL TRIAL DESIGN

• The Importance Of Diversity In Clinical Trials

  A recent FDA draft guidance aims to address health disparities and enhance data quality with action plans for greater inclusivity in clinical trials. Explore practical steps to building trust and inclusivity in clinical research.

• Beyond Meeting Rooms: Maximizing Virtual And Hybrid Meeting Success

  When face-to-face interactions aren't ideal, virtual and hybrid meetings can provide unique benefits that enhance your clinical trial experience.

• Meeting Regulatory And Patient Needs By Improving Clinical Trial Access

  Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.

• Integrating Clinical Operations And Pharmacovigilance for Safer Trials

  Learn how integrated planning strengthens decision-making, reduces downstream risk, and supports patient safety while protecting timelines in high-risk studies.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  4/3/2025

  In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.

• Reducing The Burden Of Patient Retention And Improving Continuity

  1/6/2026

  Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.

• A New Blueprint For Transforming Feasibility And Recruitment

  9/22/2025

  Discover how a connected approach links feasibility and recruitment, using real-world data to design realistic protocols, reach the right patients, and accelerate enrollment with confidence.

• Data Key In Addressing Patient Recruitment Challenges

  6/19/2025

  Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.

• Combination Therapy Dose Optimization In Oncology Trials

  3/30/2026

  Optimize dose selection in oncology trials by moving beyond toxicity limits. Use advanced modeling and benefit-risk analysis to improve efficacy and meet modern regulatory standards.